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INTRODUCTION
There have been many reports that a high-fat diet
causes insulin resistance (1-3) and consumption
of saturated fatty acids (SFA) induces hyperlipide-
mia and obesity, causing progression of arterioscle-
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rosis (4, 5). There have been many reports that con-
sumption of polyunsaturated fatty acids (PUFA) leads
to improvement of hyperlipidemia and prevention
of arteriosclerosis (6, 7). However, there have been
a few reports of an association between blood satu-
rated fatty acid concentrations or unsaturated fatty
acid concentrations and insulin resistance. In pre-
sent study, we measured the serum fatty acid con-
centrations in patients with type 2 diabetes mellitus
and investigated the relations between the homeo-
stasis model insulin resistance index, HOMA-R (8),
and the serum fatty acid concentrations. Early morn-
ing fasting blood specimens were collected from 93
outpatients (70 men and 23 women) attending the
outpatient clinic of Aichi Medical University Hos-
pital, and their serum fatty acid concentrations were
measured. Their serum insulin concentration was
measured at the same time, and the correlations be-
tween serum fatty acid concentrations and HOMA-R
were calculated.
SUBJECTS AND METHODS
Study Population
The study was conducted on 93 type 2 diabetes
mellitus patients (70 men and 23 women, mean age
54 (SD 11) years old, body mass index 23.3 (SD
4.8)) attending the outpatient clinic for the treatment
of diabetes at the Aichi Medical University Hospital.
They were treated with hypoglycemic agents (pio-
glitazone, sulfonylurea, or α-glucosidase inhibitor)
and dietetic therapy or both for 2-3 years.
Morning blood samples were collected after a
12-hour fast. The serum was separated from the
blood within 1 hour, and serum samples were used
to measure the concentrations of glucose, insulin,
and fatty acids. All procedures were performed at
4or on ice water.
Informed consent was obtained from all the sub-
jects, and the study protocol was approved by the
ethics committee.
Serum glucose and insulin analysis
Serum glucose was determined by conventional
enzymatic methods at SRL Inc. (Tokyo, Japan). Se-
rum insulin was determined by a conventional en-
zyme immunoassay with the Glazyme insulin-EIA
test (Wako Pure Chemical Industries) at SRL Inc.
Serum fatty acids
Approximately 0.2 ml of serum samples and 2 ml
of chloroform-methanol (2 : 1) solution were placed
in Pyrex centrifuge tubes, homogenized with a Poly-
tron (PCU-2-110, KINEMATICA GmbH, Switzer-
land), and then centrifuged at 3000 rpm for 10 min.
An aliquot of the chloroform-methanol extract was
transferred to another Pyrex tube and dried under a
stream of nitrogen gas. The dried specimens were
dissolved in 100 μl 0.4M potassium methoxide-
methanol/14% boron trifluoride-methanol solution,
and the fatty acid concentrations in the solution were
measured with a gas chromatograph (Shimazu GC
17A, Kyoto, Japan) at SRL Inc.
Statistical analysis
The correlation analysis was performed by Spear-
man’s test. P values less than 0.05 were considered
significant.
RESULTS
The fasting serum glucose levels in the diabetic
patients were 13543 mg/dl, insulin levels were
8.618.05 μU/ml, and HOMA-R were 2.912.75.
The fasting serum FFA levels are shown in Table 1.
Regarding the fasting serum glucose, insulin,
HOMA-R, and FFA levels, no sex difference was
noted.
The correlations between serum SFA concentra-
tions and HOMA-R are shown in Table 2. The SFA
that were positively correlated with HOMA-R were
lauric acid (C12 : 0), myristic acid (C14 : 0), palmitic
acid (C16 : 0), and stearic acid (C18 : 0). No corre-
lations were found with regard to arachidic acid (C
20 : 0), behenic acid (C22 : 0), and lignoceric acid
(C24 : 0).
The correlations between the serum MUFA con-
centrations and HOMA-R are shown in Table 3. The
MUFA that were positively correlated with HOMA-R
were palmitoleic acid (C16 : 1), oleic acid (C18 : 1),
and erucic acid (C22 : 1). No correlations were found
with regard to eicosanoic acid (C20 : 1) and nervonic
acid (C24 : 1).
The correlations between the PUFA serum con-
centration and HOMA-R are shown in Table 4. The
PUFA that were positively correlated with HOMA-R
were eicosadienoic acid (C20 : 2), dihomo-γ-linolenic
acid (C20 : 3), docosatetraenoic acid (C22 : 4), and
docosapentaenoic acid (C22 : 5). No correlations
were found with regard to linoleic acid (C18 : 2), γ-
linolenic acid (C18 : 3), linolenic acid (C18 : 3), 5-8-
11 eicosatrienoic acid (C20 : 3), arachidonic acid
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(C20 : 4), eicosapentaenoic acid (C20 : 5), and do-
cosahexaenoic acid (C22 : 6).
DISCUSSION
Consumption of SFA induces hyperlipidemia,
causing progression of arteriosclerosis (4, 5). How-
ever, there have been many reports that consump-
tion of PUFA leads to improvement of hyperlipide-
mia and prevention of arteriosclerosis (6, 7), In hu-
man (6, 7) and animal studies, a hyperlipidemia-
ameliorating action and cardiovascular disease pre-
venting action have also been found to result from
intake of omega-3 fatty acids (9, 10). On the other
hand, there have been few reports on the relation
between fatty acid intake and glucose metabolism
or insulin resistance in diabetics, and there have also
been few reports describing an association between
blood SFA or unsaturated fatty acid concentrations
and insulin resistance.
In an animal study, Storlien LH, et al. fed rats
saturated fatty acids and reported that when they
fed the rats food containing omega-3 fatty acids after
inducing insulin resistance, the insulin resistance
improved (11). In the present study, we measured
the serum fatty acid concentrations of diabetic pa-
tients and investigated the relation between an in-
dex of insulin resistance, HOMA-R, and serum fatty
acid concentrations.
In the present study, we predicted that there
would be a positive correlation between serum SFA
concentrations and HOMA-R and there would be a
negative correlation between the serum concentra-
tions of PUFA and HOMA-R. More specifically, we
predicted that the serum concentrations of PUFA
in patients with mild insulin resistance would be
higher than those of patients with severe insulin re-
sistance and that their serum concentrations of SFA
would be low.
Table 3. The relationship between the serum levels of monoun-
saturated fatty acids and the HOMA-R
Correlation coefficient ( r ) P value
Palmitoleic acid (C16 : 1) 0.4053 0.0001
Oleic acid (C18 : 1) 0.2890 0.0052
Eicosenoic acid (C20 : 1) 0.1053 0.3177
Erucic acid (C22 : 1) 0.2482 0.0171
Nervonic acid (C24 : 1) -0.0894 0.3966
Table 2. The relationship between the serum levels of satu-
rated fatty acids and the HOMA-R
Correlation coefficient ( r ) P value
Lauric acid (C12 : 0) 0.2169 0.0497
Myristic acid (C14 : 0) 0.3903 0.0001
Palmitic acid (C16 : 0) 0.3523 0.0006
Stearic acid (C18 : 0) 0.2543 0.0144
Arachidic acid (C20 : 0) 0.0438 0.6787
Behenic acid (C22 : 0) -0.0327 0.7567
Lignoceric acid (C24 : 0) -0.0589 0.5767
Table 1. Fasting serum FFA levels in patients with type 2 dia-
betic meditus
FFA μg/ml
Lauric acid (C12 : 0) 1.91.4
Myristic acid (C14 : 0) 32.118.3
Palmitic acid (C16 : 0) 837.7245.2
Stearic acid (C18 : 0) 247.560.8
Arachidic acid (C20 : 0) 8.31.7
Behenic acid (C22 : 0) 21.24.6
Lignoceric acid (C24 : 0) 18.83.9
Palmitoleic acid (C16 : 1) 79.935.4
Oleic acid (C18 : 1) 734.0247.6
Eicosenoic acid (C20 : 1) 6.33.0
Erucic acid (C22 : 1) 1.80.8
Nervonic acid (C24 : 1) 39.27.9
Linoleic acid (C18 : 2, ω6) 955.9218.3
γ-linolenic acid (C18 : 3, ω6) 11.37.1
Linolenic acid (C18 : 3, ω3) 28.514.3
Eicosadienoic acid (C20 : 2, ω6) 6.82.0
5-8-11 eicosatrienoic acid (C20 : 3, ω9) 1.90.9
Dihomo-γ-kinolenic acid (C20 : 3, ω6) 37.413.8
Arachidonic acid (C20 : 4, ω6) 191.348.2
Eicosapentaenoic acid (C20 : 5, ω3) 92.546.5
Docosatetraenoic acid (C22 : 4, ω6) 4.31.5
Docosapentaenoic acid (C22 : 5, ω3) 27.49.8
Docosahexaenoic acid (C22 : 6, ω3) 175.357.9
Data expressed as meansS.D. (n = 93).
Table 4. The relationship between the serum levels of poly-
unsaturated fatty acids and the HOMA-R
Correlation coefficient ( r ) P value
Linoleic acid (C18 : 2, ω6) 0.1115 0.2901
γ-linolenic acid (C18 : 3, ω6) 0.1321 0.2094
Linolenic acid (C18 : 3, ω3) 0.1769 0.0916
Eicosadienoic acid (C20 : 2, ω6) 0.2570 0.0134
5-8-11 eicosatrienoic acid (C20 : 3, ω9) 0.1428 0.1744
Dihomo-γ-kinolenic acid (C20 : 3, ω6) 0.3568 0.0005
Arachidonic acid (C20 : 4, ω6) 0.1137 0.2804
Eicosapentaenoic acid (C20 : 5, ω3) 0.1740 0.0971
Docosatetraenoic acid (C22 : 4, ω6) 0.2241 0.0318
Docosapentaenoic acid (C22 : 5, ω3) 0.2834 0.0064
Docosahexaenoic acid (C22 : 6, ω3) 0.1877 0.0732
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The results showed positive correlations between
HOMA-R and the concentrations of the SFA, i.e.,
lauric acid (C12), myristic acid (C14), palmitic acid
(C16), and stearic acid (C18), but no correlations
with arachidic acid (C20), behenic acid (C22), or
lignoceric acid (C24). These results suggest that the
concentrations of SFA containing a short carbon
atom chain (C12-C18) are more positively correlated
with HOMA-R than the concentrations of SFA with
a long carbon atom chain (C20-C24), and that the se-
verity of insulin resistance is related to a short car-
bon chain.
With regard to the MUFA, the concentrations of
palmitoleic acid (C16 : 1), oleic acid (C18 : 1), and
erucic acid (C22 : 1) were positively correlated with
HOMA-R, but no correlations were observed with
eicosanoic acid (C20 : 1) or nervonic acid (C24 : 1).
No associations were found between the carbon
chain length of MUFA and HOMA-R.
Kusunoki, et al. administered omega-3 fatty acids
to OLETF rats, an animal model of diabetes, and re-
ported that they improved their insulin resistance
(12). There are reports on omega-3 fatty acids as rep-
resentative PUFA, stating that intake of PUFA im-
proves hyperlipidemia in diabetics and prevents the
progression of arteriosclerosis (13-15). Therefore,
negative correlations were predicted between the
concentrations of PUFA and HOMA-R. However,
none of the PUFA were found to be negatively cor-
related with HOMA-R in this study. In contrast, posi-
tive correlations were found with eicosadienoic acid
(C20 : 2, ω6), dihomo-γ-linolenic acid (C20 : 3, ω6),
docosapentaenoic acid (C20 : 5, ω3), and docosatet-
raenoic acid (C22 : 4, ω6), but no correlations were
found between HOMA-R and following seven fatty
acids, linoleic acid (C18 : 2, ω6), γ-linolenic acid (C
18 : 3, ω6), linolenic acid (C18 : 3, ω3), 5-8-11 ei-
cosatrienoic acid (C20 : 3, ω9), arachidonic acid (C
20 : 4, ω6), eicosapenataenoic acid (C20 : 5, ω3), or
docosahexaenoic acid (C22 : 6, ω3). No correlations
were found between the carbon chain length of PUFA
and HOMA-R, and no associations were found be-
tween HOMA-R and the ω3 fatty acids or ω6 fatty
acids.
CONCLUSION
The results of this study showed that some PUFA
as well as SFA were positively correlated with
HOMA-R, in other words, indicating that intake of
those fatty acids aggravates insulin resistance. Among
the SFA, positive correlations were found with re-
gard to the concentrations of SFA that have short
carbon chains as compared to the concentrations of
SFA that have long carbon chains, and there ap-
peared to be an association between the severity of
insulin resistance and SFA with short carbon chains.
No trends were observed in the correlations be-
tween the concentrations of MUFA or PUFA and
HOMA-R. These results indicate that the intake of
diet fatty acid must be well balanced in diabetic pa-
tients and it is not always true that they should re-
frain from taking SFA and increase the unsaturated
fatty acids in their diets.
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